Evidence map›Paper›PMID 27488662›Full record

ArticleAmerican journal of physiology. Cell physiology2016

Ketoisocaproic acid, a metabolite of leucine, suppresses insulin-stimulated glucose transport in skeletal muscle cells in a BCAT2-dependent manner.

Mahshid Moghei, Pegah Tavajohi-Fini, Brendan Beatty, Olasunkanmi A J Adegoke

Open access · bronzeAbstract read
In one paragraph

Article in American journal of physiology. Cell physiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 62 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Review
  4. Review
  5. Review
  6. Exogenous Nucleotides Supplementation Attenuates Age-Related Sarcopenia.Journal of cachexia, sarcopenia and muscle · 2025
    Article
  7. Alpha-Ketoisocaproate Attenuates Muscle Atrophy in Cancer Cachexia Models.Journal of cachexia, sarcopenia and muscle · 2025
    Article
  8. Review
  9. Article
  10. Branched-chain amino acid metabolism: Pathophysiological mechanism and therapeutic intervention in metabolic diseases.Obesity reviews : an official journal of the International Association for the Study of Obesity · 2025
    Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Mahshid MogheiSchool of Kinesiology and Health Science and Muscle Health Research Centre, York University, Toronto, Ontario, Canada.
Pegah Tavajohi-FiniSchool of Kinesiology and Health Science and Muscle Health Research Centre, York University, Toronto, Ontario, Canada.
Brendan BeattySchool of Kinesiology and Health Science and Muscle Health Research Centre, York University, Toronto, Ontario, Canada.
Olasunkanmi A J AdegokeSchool of Kinesiology and Health Science and Muscle Health Research Centre, York University, Toronto, Ontario, Canada oadegoke@yorku.ca.
York University · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although leucine has many positive effects on metabolism in multiple tissues, elevated levels of this amino acid and the other branched-chain amino acids (BCAAs) and their metabolites are implicated in obesity and insulin resistance. While some controversies exist about the direct effect of leucine on insulin action in skeletal muscle, little is known about the direct effect of BCAA metabolites. Here, we first showed that the inhibitory effect of leucine on insulin-stimulated glucose transport in L6 myotubes was dampened when other amino acids were present, due in part to a 140% stimulation of basal glucose transport (P < 0.05). Importantly, we also showed that α-ketoisocaproic acid (KIC), an obligatory metabolite of leucine, stimulated mTORC1 signaling but suppressed insulin-stimulated glucose transport (-34%, P < 0.05) in an mTORC1-dependent manner. The effect of KIC on insulin-stimulated glucose transport was abrogated in cells depleted of branched-chain aminotransferase 2 (BCAT2), the enzyme that catalyzes the reversible transamination of KIC to leucine. We conclude that although KIC can modulate muscle glucose metabolism, this effect is likely a result of its transamination back to leucine. Therefore, limiting the availability of leucine, rather than those of its metabolites, to skeletal muscle may be more critical in the management of insulin resistance and its sequelae.

Indexed as

Amino AcidsAnimalsBiological TransportCells, CulturedGlucoseInsulinInsulin ResistanceKeto AcidsLeucineMechanistic Target of Rapamycin Complex 1Membrane Transport ProteinsMitochondrial ProteinsMonocarboxylic Acid TransportersMultiprotein ComplexesMuscle Fibers, SkeletalMuscle, Skeletalalpha-ketoisocaproic acidAmino AcidsBcat2 protein, ratbranched-chain-amino-acid transaminaseGlucoseInsulinKeto AcidsLeucineMechanistic Target of Rapamycin Complex 1Membrane Transport ProteinsMitochondrial ProteinsMonocarboxylic Acid TransportersMultiprotein ComplexesTOR Serine-Threonine KinasesTransaminasesglucose transportinsulin resistanceleucinemTORC1α-ketoisocaproic acid

Identifiers

PMID27488662
PMCPMC5129764
OpenAlexW2477754538

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.